Leave Your Message

Ultra Nuclease-HYI221

Ultra Nuclease is a genetically engineered endonuclaese derived from Serratia marcescens, which is capable of degrade DNA or RNA, either double or single stranded, linear or circular under a wide range of condition, completely degrade nucleic acids into 5’-monophosphate oligonucleotides with 3-5 base length.

Cat No.: HYI221

Specification: 5 KU/50KU/500KU/5000KU

    Ultra Nuclease is a genetically engineered endonuclaese derived from Serratia marcescens, which is capable of degrade DNA or RNA, either double or single stranded, linear or circular under a wide range of condition, completely degrade nucleic acids into 5’-monophosphate oligonucleotides with 3-5 base length. After genetic engineering modification, the product was fermented, expressed, and purified in E. coli, which reduces the viscosity of cell supernatant and cell lysate in scientific research, but also improve the purification efficiency and functional research of protein. It can also be used in the gene therapy, virus purification, vaccine production, protein and polysaccharide pharmaceutical industry as a host residue nucleic acid removal reagent.

    Components

    Components

    5 KU

    50KU

    500KU

    5000KU

    Ultra Nuclease

    20μL

    200μL

    2mL

    20mL

    Product Features

    CAS No.

    9025-65-4

    EC No.

    3.1.30.2

    Molecular Weight

    30kDa

    Isoelectric Point

    6.85

    Protein Purity

    ≥99%(SDS-PAGE & SEC-HPLC)

    Specific Activity

    ≥1.1×106U/mg

    Optimum Temperature

    37°C

    Optimum pH

    8.0

    Protease Activity

    negative

    Bioburden

    <10CFU/100,000U

    Residual Host-cell Protein

    ≤10ppm

    Heavy Metal

    ≤10ppm

    Bacterial Endotoxin

    <0.25EU/1000U

    Storage Buffer

    20mM Tris-HCl, pH 8.0, 2mM MgCl2, 20mM

    NaCl,50% Glycerol

    Storage

    ≤0°C transportation;-25~-15°C Storage,2 years validity (avoid freezing-thawing)

    Unit Definition

    The amount of enzyme used to change the absorption value of A260 by 1.0 within 30min at 37 °C, pH 8.0, equivalent to digested 37μg salmon sperm DNA by cutting into oligonucleotides, was defined as an active unit (U).

    Quality Control

    1. Residual Host-cell Protein: ELISA kit
    2. Protease Residues: 250KU/mL Ultra Nuclease reacted with substrate for 60min, no activity was detected.
    3. Bacterial Endotoxin: LAL-Test, Pharmacopoeia of the People’s Republic of China Volume 4 (2020 Edition) gel limit test method. General Rules(1143).
    4. Bioburden: Pharmacopoeia of the People’s Republic of China Volume 4 (2020 Edition)—General Rules for Sterility Test (1101), PRC National Standard, GB 4789.2-2016.
    5. Heavy Metal: ICP-AES, HJ776-2015.

    Operation

    1. UltraNuclease activity was significantly inhibited when SDS concentration was over 0.1% or EDTA concentration was over 1mM.
    2. Surfactant Triton X-100, Tween 20 and Tween 80 had no effect on nuclease properties when the concentration was under 1.5%.

    Operation

    Optimal Operation

    Valid Operation

    Temperature

    37℃

    0-45℃

    pH

    8.0-9.2

    6.0-11.0

    Mg 2+

    1-2mM

    1-15mM

    DTT

    0-100mM

    >100mM

    2-Mercaptoethanol

    0-100mM

    >100mM

    Monovalent metal ion(Na +,K+ etc.)

    0-20mM

    0-200mM

    PO4 3-

    0-10mM

    0-100mM

    “Optimal” is defined as the condition under which UltraNuclease retains > 90% of its activity “Effective” is defined as the condition under which UltraNuclease retains > 15% of its activity.

    Usage and Dosage

    1. Remove exogenous nucleic acid from vaccine products, reduce the risk of residual nucleic acid toxicity and improve product safety.
    2. Reduce the viscosity of feed liquid caused by nucleic acid, shorten processing time and increase protein yield.
    3. Remove the nucleic acid which wrapped particle (virus, inclusion body, etc.), which is conducive to the release and purification of the particle.
    4. Nuclease treatment can improve the resolution and recovery of the sample for column chromatography, electrophoresis and blotting analysis.
    5. In gene therapy, nucleic acid is removed to obtain purified adeno-associated viruses.

    Experimental Type

    Protein Production

    Virus, Vaccine

    Cell Drugs

    Cells Number

    1g cell wet weight (resuspended

    with 10 ml buffer)

    1L fermentation

    Liquid supernatant

    1L culture

    Minimum Dosage

    250U

    100U

    100U

    Recommended Dosage

    2500U

    25000U

    5000U

    Function Time

    Recommended reaction at 37 ℃ for 15~60min, or

    reaction at 25℃ for 30~120min

    If the solution is high-salinity, acidic or alkaline or with high concentration of detergent denaturant, it should be appropriate to increase the amount of enzyme or extend the incubation time.

    Notes

    1. Storage of UltraNuclease at 4 °C for two weeks does not affect the biological activity, long-term storage at 4°C is not recommended.
    2. Avoid freezing-thawing at -80 °C, recommended storage at -25~-15 °C.
    3. Avoid contamination by contact with other enzymes used in molecular diagnosis during application.
    4. For your safety and health, please wear lab coat and gloves.

    Leave Your Message